Assistant Professor, Medicine, Perelman School of Medicine
Infectious Disease
Dr. Rahul M. Kohli, MD
|
|
Give Review
Rahul M. Kohli, MD works in the field of Infectious Disease. He graduated from Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School has a rank of 1 in research and a 12 in primary care Rahul Kohli is a published physician. He published 32 publications, including: 'The oxidative half-reaction of Old Yellow Enzyme. The role of tyrosine 196.' He accepts Medicare.
Publications
- Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.
- Specificity Determinants for Autoproteolysis of LexA, a Key Regulator of Bacterial SOS Mutagenesis.
- Molecular targeting of mutagenic AID and APOBEC deaminases.
- TET enzymes, TDG and the dynamics of DNA demethylation.
- Nucleic acid determinants for selective deamination of DNA over RNA by activation-induced deaminase.
- APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription.
- AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation.
- The Curious Chemical Biology of Cytosine: Deamination, Methylation,and Oxidation as Modulators of Genomic Potential.
- Molecular biology. Demystifying DNA demethylation.
- Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.
- Grand challenge commentary: The chemistry of a dynamic genome.
- Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs.
- A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
- When to think of zebras.
- The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.
- Enhanced macrocyclizing activity of the thioesterase from tyrocidine synthetase in presence of nonionic detergent.
- Type II thioesterase restores activity of a NRPS module stalled with an aminoacyl-S-enzyme that cannot be elongated.
- Chemoenzymatic route to macrocyclic hybrid peptide/polyketide-like molecules.
- Enzymology of acyl chain macrocyclization in natural product biosynthesis.
- Characterization of the surfactin synthetase C-terminal thioesterase domain as a cyclic depsipeptide synthase.
- Biomimetic synthesis and optimization of cyclic peptide antibiotics.
- Timing of epimerization and condensation reactions in nonribosomal peptide assembly lines: kinetic analysis of phenylalanine activating elongation modules of tyrocidin...
- Structural basis for the cyclization of the lipopeptide antibiotic surfactin by the thioesterase domain SrfTE.
- The thioesterase domain from a nonribosomal peptide synthetase as a cyclization catalyst for integrin binding peptides.
- A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy.
- The oxidative half-reaction of Old Yellow Enzyme. The role of tyrosine 196.
- The role of threonine 37 in flavin reactivity of the old yellow enzyme.
- Generality of peptide cyclization catalyzed by isolated thioesterase domains of nonribosomal peptide synthetases.
- Cyclization of backbone-substituted peptides catalyzed by the thioesterase domain from the tyrocidine nonribosomal peptide synthetase.
- Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase.
- Chain termination steps in nonribosomal peptide synthetase assembly lines: directed acyl-S-enzyme breakdown in antibiotic and siderophore biosynthesis.
Schools
Harvard Medical School
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Choice Plus POS II
- Amalgamated Clothing & Textile Workers Union WC
- Personal Choice PPO
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Blue Card PPO
- Cigna HMO
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- CoreSource
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- HealthPartners
- Community Blue PPO
- Choice Care PPO
- Keystone Health Plan East HMO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- Freedom Plan
- QualCare HMO
- QualCare PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Education
-
Johns Hopkins University -
University of Pennsylvania Health System -
Harvard Medical School
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1225174105 | |
| NPPES Provider LastName | KOHLI | |
| NPPES Provider FirstName | RAHUL | |
| NPPES Provider ZIPCode | 191044206 | |
| NPPES Provider State | PA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 116.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 13.79 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225174105 |
| Last Name Of The Provider | KOHLI |
| First Name Of The Provider | RAHUL |
| View All |
Similar Doctors
|
|
Dr. Frank P. Hudson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vincent M. Lo Re III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jerry Zuckerman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick L. McLeroth, MD |
|
|
Dr. Marissa B. Wilck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valerie C. Cluzet, MD
This Doctor is OpenDoctor Recommended.
|